Relationship between survival and chemotherapy.

<p>Relationship between survival and chemotherapy.</p

Elderly Cancer Patients' Chemo-Refusing Reason Questionnaire (ECPCRRQ).

<p>Elderly Cancer Patients' Chemo-Refusing Reason Questionnaire (ECPCRRQ).</p

The summary of subjective chemo-refusing reasons.

<p>The summary of subjective chemo-refusing reasons.</p

The chart of study design.

<p>The chart of study design.</p

The summary of chemo-refusing reasons as shown in Table 3.

<p>1. The doctor wasn’t sure of the benefit of chemotherapy and didn’t recommend chemotherapy.</p><p>2. The patient trusted and used Traditional Chinese Medicine only.</p><p>3. Economic difficulty.</p><p>4. The patient was feeling uncomfortable but did other positive measures such as diet control.</p><p>5. Admitting difficulty.</p><p>6. Family members concealed the disease information to the patient.</p><p>7. Fearing of chemotherapy or lack of family support.</p><p>8. The patient was dealing with complication first and delayed chemotherapy.</p><p>9. The patient was feeling despair and refused treatment.</p><p>10. The patient couldn’t tolerate side effects of chemotherapy.</p

Variables in the equation.

<p>BSA: body surface area; BMI: body mass index; CEA: carcinoembryonic antigen; WBC: white blood cell; NE: neutrophils; HGB: hemoglobin; PLT: platelet; ALT: glutamic pyruvic transaminase; AST: glutamic oxalacetictransaminease; ALP: alkaline phosphatase; TP: total protein; ALB: albumin; TB: total bilirubin; CR: creatinine.</p

MOESM1 of Synthetic lethal short hairpin RNA screening reveals that ring finger protein 183 confers resistance to trametinib in colorectal cancer cells

Additional file 1: Table S1. Abundance of genomic short hairpin RNA (shRNA) fragments under different conditions

Additional file 1 of The effects of oxaliplatin-based adjuvant chemotherapy in high-risk stage II colon cancer with mismatch repair-deficient: a retrospective study

Additional file 1: Fig S1. Flow of study